Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

2013105 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: British Journal of Cancer

Volume 109, Issue 3, pp. 552-558

Field-Weighted Citation Impact: 7.56